UT Southwestern Medical Centre
Welcome,         Profile    Billing    Logout  
 25 Trials 
49 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rahimi, Asal
RAPS, NCT06444269: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI () and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: Trial

Recruiting
2
53
US
Radiomics on MRI, microbubble CEUS Contrast Enhanced Ultrasound (CEUS)
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/28
NCT04040569: A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer

Active, not recruiting
1
45
US
Radiomics on MRI
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/27
NCT02685332: Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA

Active, not recruiting
1
30
US
Stereotactic Radiation, SB-PBI
University of Texas Southwestern Medical Center
Early Stage Breast Cancer
06/26
06/26
NCT02170181: Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation

Recruiting
N/A
5000
NA
SBRT, Stereotactic body radiation therapy
University of Texas Southwestern Medical Center
Cancer Patients Receiving Stereotactic Body RTX
12/26
12/26
GCC 1876, NCT03562273: GammaPod Registry and Quality of Life Nomogram

Recruiting
N/A
160
US
Quality Of Life Sizing Nomogram, GammaPod Quality Of Life Sizing Nomogram
University of Maryland, Baltimore, University of Texas, Southwestern Medical Center at Dallas
Breast Cancer Female
12/26
12/27
NCT03581136: Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod

Active, not recruiting
N/A
74
US
Dose Fractionation
University of Texas Southwestern Medical Center
Breast Cancer
05/28
06/30
Iyengar, Puneeth
NCT01459497: Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer

Completed
3
103
US
Radiation Therapy, Conventional radiation
University of Texas Southwestern Medical Center
Non-small Cell Lung Cancer
07/19
10/23
NRG-LU002, NCT03137771: Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Active, not recruiting
2
218
Canada, US, RoW
3-Dimensional Conformal Radiation Therapy (3D-CRT), 3-dimensional conformal radiation therapy, 3-dimensional radiation therapy, 3D CONFORMAL RADIATION THERAPY, 3D CRT, 3D-CRT, Conformal Therapy, Radiation Conformal Therapy, Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Gemcitabine, dFdC, dFdCyd, Difluorodeoxycytidine, Intensity-Modulated Radiation Therapy (IMRT), IMRT, Intensity Modulated RT, INTENSITY-MODULATED RADIATION THERAPY, Intensity-Modulated Radiotherapy, Pemetrexed Disodium, Alimta, LY231514, N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt, Stereotactic Body Radiation Therapy (SBRT), SBRT, stereotactic body radiation therapy, Erlotinib Hydrochloride, Tarceva, Pembrolizumab, Keytruda
NRG Oncology, National Cancer Institute (NCI)
Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer
12/23
12/28
GRECO-1, NCT04476797: Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC

Terminated
1/2
47
US
GC4711 +SBRT, rucosopasem manganese, Placebo +SBRT
Galera Therapeutics, Inc.
SBRT, NSCLC, Non-metastatic
11/23
11/23
NCT04906746: Ruxolitinib for Cancer Cachexia

Recruiting
1
10
US
Identify any dose-limiting toxicity (DLT) when ruxolitinib is administered to NSCLC cachexia patients.
Tu Dan, Incyte Corporation
Stage IV Non-small Cell Lung Cancer, Cachexia
02/25
02/25
NCT03568019: PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors

Active, not recruiting
N/A
10000
US
Retrospective study
University of Texas Southwestern Medical Center
Cachexia; Cancer
12/24
02/26
NCT00992303: Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Recruiting
N/A
10000
US
biologic sample preservation procedure, medical chart review, questionnaire administration
University of Texas Southwestern Medical Center
Unspecified Adult Solid Tumor, Protocol Specific
12/29
12/29
NCT03606317: Retrospective Review of Cachexia in Lung and Gastrointestinal Cancer Patients

Active, not recruiting
N/A
20000
NA
University of Texas Southwestern Medical Center, Parkland Health and Hospital System
Cachexia
03/25
03/25
Kilmer, Suzanne
NCT05882721: Treatment for Improvement of Cellulite Appearance Using Form Applicator

Completed
N/A
60
US
Sofwave
Sofwave Medical LTD
Cellulite
11/23
11/23
Folkert, Michael
GUIDANCE, NCT05050084: Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score

Recruiting
3
2050
Canada, US
Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Buserelin, 6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing Hormone-releasing Factor (Pig), BSRL, Busereline, Etilamide, HOE 766, ICI 123215, S74-6766, Darolutamide, Antiandrogen ODM-201, BAY 1841788, BAY-1841788, BAY1841788, Nubeqa, ODM 201, ODM-201, Degarelix, FE200486, Firmagon, Flutamide, 4'-Nitro-3'-trifluoromethylisobutyranilide, Apimid, Cebatrol, Chimax, Cytomid, Drogenil, Euflex, Eulexine, Flucinom, Flucinome, Flugerel, Fluken, Flulem, FLUT, Fluta-Gry, Flutabene, Flutacan, Flutamex, Flutamin, Flutan, Flutaplex, Fugerel, Grisetin, Niftolide, Oncosal, Profamid, Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, Prostacur, Prostadirex, Prostica, Prostogenat, Sch 13521, Tafenil, Tecnoflut, Testotard, Goserelin, ICI-118630, Histrelin, Leuprolide, Leuprorelin, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Relugolix, N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea, Orgovyx, TAK 385, TAK-385, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Detryptoreline
NRG Oncology, National Cancer Institute (NCI)
Prostate Adenocarcinoma
04/32
04/37
INDICATE, NCT04423211: Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Recruiting
3
804
US
3-Dimensional Conformal Radiation Therapy, 3-dimensional radiation therapy, 3D Conformal, 3D CONFORMAL RADIATION THERAPY, 3D CRT, 3D radiotherapy, 3D-CRT, Conformal Therapy, Radiation Conformal Therapy, Radiation, 3D Conformal, Three dimensional external beam radiation therapy (procedure), Apalutamide, ARN 509, ARN-509, ARN509, Erleada, JNJ 56021927, JNJ-56021927, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Degarelix, FE200486, Firmagon, External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiation, External Beam Radiotherapy, External Beam Radiotherapy (conventional), External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Radiation, External Beam, Teleradiotherapy, Teletherapy, Teletherapy Radiation, Fluciclovine F18, (18F)Fluciclovine, (18F)GE-148, 18F-Fluciclovine, [18F]FACBC, Anti-(18f)FABC, Anti-1-Amino-3-[18F]Fluorocyclobutane-1-Carboxylic Acid, Anti-[18F] FACBC, Axumin, Fluciclovine (18F), FLUCICLOVINE F-18, GE-148 (18F), GE-148 F-18, Goserelin Acetate, ZDX, Zoladex, Intensity-Modulated Proton Therapy, IMPT, Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Lutrate, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Relugolix, N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea, Orgovyx, TAK 385, TAK-385, Stereotactic Body Radiation Therapy, SABR, SBRT, Stereotactic Ablative Body Radiation Therapy, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Detryptoreline, Volume Modulated Arc Therapy, VMAT, Volumetric Modulated Arc Therapy (procedure)
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
12/32
12/32
Sher, David
NCT03811015: Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Suspended
3
636
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Patient Observation, Active Surveillance, deferred therapy, expectant management, Observation, Watchful Waiting, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
National Cancer Institute (NCI)
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
01/27
01/27
NCT05721755: Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Recruiting
3
290
US
Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized Tomography, CT, CT Scan, tomography, Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-Fu, 5FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Quality-of-Life Assessment, Quality of Life Assessment, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Oral Cavity Squamous Cell Carcinoma, Metastatic Oropharyngeal Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
03/29
03/30
NRG-HN001, NCT02135042: Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Active, not recruiting
2/3
685
Canada, US, RoW
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Clinical Observation, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Actino-Hermal, Adrucil, Arumel, Cytosafe, Efudex, Efurix, Fiverocil, Fluoro Uracil, Fluoroplex, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Flurox, Ribofluor, Ro 2-9757, Ro-2-9757, Timazin, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemzar, LY-188011, Intensity-Modulated Radiation Therapy, IMRT, Intensity Modulated RT, Intensity-Modulated Radiotherapy, Laboratory Biomarker Analysis, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Quality-of-Life Assessment, Quality of Life Assessment
NRG Oncology, National Cancer Institute (NCI)
Epstein-Barr Virus Infection, Stage II Nasopharyngeal Carcinoma, Stage III Nasopharyngeal Carcinoma, Stage IVA Nasopharyngeal Carcinoma, Stage IVB Nasopharyngeal Carcinoma
02/26
02/31
RTOG 1216, NCT01810913: Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Recruiting
2/3
613
Canada, US, RoW
Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG 7446, RG-7446, RG7446, RO 5541267, RO-5541267, RO5541267, Tecentriq, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cetuximab, C 225, C-225, C225, Cetuximab Biosimilar CDP-1, Cetuximab Biosimilar CMAB009, Cetuximab Biosimilar KL 140, Chimeric Anti-EGFR Monoclonal Antibody, Chimeric MoAb C225, Chimeric Monoclonal Antibody C225, Erbitux, IMC-C225, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Docetaxel, Docecad, RP 56976, RP-56976, RP56976, Taxotere, Taxotere Injection Concentrate, Intensity-Modulated Radiation Therapy, IMRT, Intensity modulated radiation therapy (procedure), Intensity Modulated RT, Intensity-Modulated Radiotherapy, Radiation, Intensity-Modulated Radiotherapy, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Quality-of-Life Assessment, Quality of Life Assessment
National Cancer Institute (NCI), NRG Oncology
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7, Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7, Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7, Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
01/27
01/27
NCT03953976: INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy

Completed
2
67
US
Intensity modulated radiation therapy (IMRT)
University of Texas Southwestern Medical Center
Head and Neck Squamous Cell Carcinoma
11/22
01/24
DARTBOARD, NCT04883281: A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer

Completed
2
50
US
Intensity modulated radiation therapy (IMRT) with or without chemotherapy, cisplatin, cetuximab, or carboplatin-paclitaxel
University of Texas Southwestern Medical Center
Head and Neck Cancer
09/24
09/24
NCT06477692: Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

Recruiting
2
80
US
ENI using IMRT with or without chemotherapy, cisplatin, cetuximab, or carboplatin- paclitaxel), INRT, ENI
University of Texas Southwestern Medical Center, National Cancer Institute (NCI)
Head and Neck Cancer
07/28
07/28
KEYSTROKE, NCT03546582: SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Recruiting
2
102
Canada, US
Pembrolizumab, Keytruda, Stereotactic Body Radiation Therapy (SBRT), SBRT
RTOG Foundation, Inc., Merck Sharp & Dohme LLC
Head and Neck Squamous Cell Carcinoma (HNSCC)
07/27
07/29
NCT03548285: Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer

Completed
N/A
26
US
Radiation therapy
University of Texas Southwestern Medical Center
Glottic Carcinoma
04/23
04/24
G-FORCE, NCT06080503: Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

Recruiting
N/A
67
US
LT-SABR, IMRT
University of Texas Southwestern Medical Center
Laryngeal Carcinoma
11/28
03/29
NCT03617237: Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

Recruiting
N/A
10000
US
Retrospective Populations
University of Texas Southwestern Medical Center
Cancer
07/30
04/32
Oz, Orhan
RAPID-WATER, NCT05134012 / 2021-006295-17: RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (-FLOW)

Recruiting
3
215
Europe, Canada, US
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)
MedTrace Pharma A/S, MedTrace Pharma A/S
Coronary Artery Disease
12/24
06/25
CLARIFY, NCT06056830: Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Recruiting
3
383
US, RoW
64Cu-SAR-bisPSMA
Clarity Pharmaceuticals Ltd
Prostate Cancer, Prostatic Neoplasms
02/25
02/25
AlphaBreak, NCT06402331: FPI-2265 (225Ac-PSMA-I&T) for Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Hourglass May 2024 - Dec 2024 : Completion of enrollment in P2 portion for mCRPC
Recruiting
2/3
60
US
FPI-2265, Ac225-PSMA I&T
Fusion Pharmaceuticals Inc.
Metastatic Castration-resistant Prostate Cancer
07/26
01/31
NCT04483414: 68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Withdrawn
2
50
US
68Ga PSMA-11 injection, Positron Emission Tomography/Computed Tomography, PET/CT
Dana Mathews
Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Metastatic to Bone
04/23
04/23
NCT05002465: Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer

No Longer Available
N/A
US
68Ga-PSMA-11, Positron Emission Tomography/Computed Tomography, PET/CT
Dana Mathews
Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent
 
 
NCT03568019: PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors

Active, not recruiting
N/A
10000
US
Retrospective study
University of Texas Southwestern Medical Center
Cachexia; Cancer
12/24
02/26
Neufeld, Sarah
POTEN-C, NCT03525262: Prostate Oncologic Therapy While Ensuring Neurovascular Conservation

Active, not recruiting
2
124
US
30Gy (Gray) planning target volume (PTV)
University of Texas Southwestern Medical Center, Boston Scientific Corporation
Prostate Cancer Adenocarcinoma
05/27
05/27
PROMISE, NCT05148078: Pediatric Radiation Oncology With Movie Induced Sedation Effect

Recruiting
2
30
US
PROMISE (Pediatric Radiation Oncology with Movie Induced Sedation Effect)
University of Texas Southwestern Medical Center
Pediatric Cancer
08/25
09/25
RAPS, NCT06444269: Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI () and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: Trial

Recruiting
2
53
US
Radiomics on MRI, microbubble CEUS Contrast Enhanced Ultrasound (CEUS)
University of Texas Southwestern Medical Center
Breast Cancer
07/27
07/28
NCT06477692: Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

Recruiting
2
80
US
ENI using IMRT with or without chemotherapy, cisplatin, cetuximab, or carboplatin- paclitaxel), INRT, ENI
University of Texas Southwestern Medical Center, National Cancer Institute (NCI)
Head and Neck Cancer
07/28
07/28
KEVLARx, NCT05966194: RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Recruiting
2
216
US
RRx-001, Intensity Modulated Radiation Therapy (IMRT), Cisplatin for injection 100 mg/m2
EpicentRx, Inc.
Oral Mucositis
07/25
10/25
NCT04786093: Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC

Recruiting
2
52
US
Stereotactic radiation therapy, Durvalumab
University of Texas Southwestern Medical Center
Non Small Cell Lung Cancer
05/26
05/27
NCT05021237: Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer

Recruiting
2
30
US
Ultra-fractionated radiation therapy
University of Texas Southwestern Medical Center, Elekta Limited
Stage IV Cervical Cancer FIGO 2018, Adenosquamous Carcinoma of Cervix, Cervical Cancer, Metastasis
08/28
08/28
HYHOPE, NCT04580446: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer

Completed
1
24
US
Hypofractionated intensity modulated radiotherapy
University of Texas Southwestern Medical Center, Gateway for Cancer Research
Human Papillomavirus-Related Carcinoma, Oropharyngeal Cancer
12/24
12/24
NCT06044857: PSMA PET Response Guided SabR in High Risk Pca

Recruiting
1
20
US
68-Ga PSMA11, Illucix, Telix
University of Texas Southwestern Medical Center, Once Upon a Time Foundation, Telix International Pty Ltd
Prostate Adenocarcinoma
11/26
11/26
ARTIA-Cervix, NCT05197881: Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix

Recruiting
N/A
125
US
Varian Ethos Adaptive Radiation Therapy
Varian, a Siemens Healthineers Company
Cervical Cancer by FIGO Stage 2018
05/26
05/28
NCT00992303: Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Recruiting
N/A
10000
US
biologic sample preservation procedure, medical chart review, questionnaire administration
University of Texas Southwestern Medical Center
Unspecified Adult Solid Tumor, Protocol Specific
12/29
12/29
NCT06353321: Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1

Recruiting
N/A
25
US
PET-CT imaging subsystem of the RefleXion X1 System Device
University of Texas Southwestern Medical Center, RefleXion Medical
Prostate Cancer
12/25
12/25
G-FORCE, NCT06080503: Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

Recruiting
N/A
67
US
LT-SABR, IMRT
University of Texas Southwestern Medical Center
Laryngeal Carcinoma
11/28
03/29
NCT03617237: Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

Recruiting
N/A
10000
US
Retrospective Populations
University of Texas Southwestern Medical Center
Cancer
07/30
04/32
Gilmore, Linda A
NCT03568019: PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors

Active, not recruiting
N/A
10000
US
Retrospective study
University of Texas Southwestern Medical Center
Cachexia; Cancer
12/24
02/26
NCT03606317: Retrospective Review of Cachexia in Lung and Gastrointestinal Cancer Patients

Active, not recruiting
N/A
20000
NA
University of Texas Southwestern Medical Center, Parkland Health and Hospital System
Cachexia
03/25
03/25

Download Options